Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AHPA pushes agency on guidance

This article was originally published in The Tan Sheet

Executive Summary

FDA is urged to publish overdue guidance for reporting serious adverse events in an Oct. 4 letter by the American Herbal Products Association. Under the adverse event law that goes into effect Dec. 22, the guidance should have been published by Sept. 18, AHPA notes. "Congress clearly intended that businesses would have at least 90 days to digest the FDA's guidance and make any necessary changes" to comply with the law, the association says. AHPA also asks the agency to consider exercising enforcement discretion. AHPA provided FDA suggestions on the guidance in August (1"The Tan Sheet" Aug. 20, 2007, p. 13)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100965

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel